Neuropace
NPCE
NPCE
24 hedge funds and large institutions have $82M invested in Neuropace in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
Holders
24
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$592K | |
| 2 | +$322K | |
| 3 | +$277K | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$200K |
| 5 |
Millennium Management
New York
|
+$184K |
Top Sellers
| 1 | -$108K | |
| 2 | -$35.5K | |
| 3 | -$35.3K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$25.1K |
| 5 |
BlackRock
New York
|
-$9.63K |